Putnam BioRevolution ETF
SYNB
SYNB was delisted on the 13th of November, 2025.
4 hedge funds and large institutions have $3.58M invested in Putnam BioRevolution ETF in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
1.68% more ownership
Funds ownership: 70.62% → 72.3% (+1.7%)
1% more capital invested
Capital invested by funds: $3.56M → $3.58M (+$28.3K)
0% more funds holding
Funds holding: 4 → 4 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$16.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $3.54M | – | – | – |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $43K | -$16.2K | -592 | -28% |
|
3
UBS Group
Zurich,
Switzerland
| $368 | – | – | – |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $56 | – | – | – |
|
SYNB Hedge Fund Activity: Q2 2025 in Review
4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q2 2025, worth a combined $3.58M — up 0.8% from $3.56M a quarter earlier.
Fund positioning in SYNB was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Royal Bank of Canada, cutting an estimated $16.2K.
- 4 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $3.58M of Putnam BioRevolution ETF stock for Q2 2025, up 0.8% quarter-over-quarter.
- 0 funds opened new Putnam BioRevolution ETF positions in Q2 2025 and 0 closed out.
- The largest Putnam BioRevolution ETF seller in Q2 2025 was Royal Bank of Canada, an estimated $16.2K sold.
Based on aggregated 13F filings for Q2 2025.